107 related articles for article (PubMed ID: 229712)
41. Acute effects of MK421, a new angiotensin converting enzyme inhibitor, in man.
Kasai Y; Abe K; Yasujima M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K; Tanno M
Tohoku J Exp Med; 1983 Dec; 141(4):417-22. PubMed ID: 6322384
[TBL] [Abstract][Full Text] [Related]
42. Plasma bradykinin levels and urinary kallikrein excretion in normal renin essential hypertension.
Mersey JH; Williams GH; Emanuel R; Dluhy RG; Wong PY; Moore TJ
J Clin Endocrinol Metab; 1979 Apr; 48(4):642-7. PubMed ID: 429510
[No Abstract] [Full Text] [Related]
43. [Urinary kallikrein activity in a hyporeninemic hypoaldosteronism syndrome].
Mezzano S; González J; Hott H; Vío CP
Rev Med Chil; 1984 Apr; 112(4):364-8. PubMed ID: 6385179
[No Abstract] [Full Text] [Related]
44. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
Rössler R
Dtsch Med Wochenschr; 1975 Nov; 100(47):2443-8. PubMed ID: 171132
[TBL] [Abstract][Full Text] [Related]
45. Relationship between kallikrein and PRA after intravenous furosemide.
Cinotti GA; Stirati G; Taggi F; Ronci R; Simonetti BM; Pierucci A
J Endocrinol Invest; 1979; 2(2):147-50. PubMed ID: 489923
[TBL] [Abstract][Full Text] [Related]
46. The kallikrein-kinin and renin-angiotensin systems in nephrotic syndrome.
Cumming AD; Jeffrey S; Lambie AT; Robson JS
Nephron; 1989; 51(2):185-91. PubMed ID: 2644571
[TBL] [Abstract][Full Text] [Related]
47. [Studies on kallikrein-kinin system in essential hypertension: urinary kallikrein-kinin system and renin-angiotensin-aldosterone system (author's transl)].
Abe K; Irokawa N; Seino M; Sakurai Y; Yasujima M; Chiba S; Ito T; Saito K; Miyazaki S; Imai Y; Kusaka T; Ritz K; Sato M; Haruyama T; Otsuka Y; Yoshinaga K; Saito T
Nihon Naika Gakkai Zasshi; 1978 May; 67(5):483-94. PubMed ID: 670775
[No Abstract] [Full Text] [Related]
48. Relationship between aldosterone and bradykinin.
Mersey JH; Williams GH; Hollenberg NK; Dluhy RG
Circ Res; 1977 May; 40(5 Suppl 1):I84-8. PubMed ID: 870233
[TBL] [Abstract][Full Text] [Related]
49. Effect of vibration on the activity of the plasma kallikrein-kinin system in the rat.
Gáti T; Budavári I; Szombath D; Losonczy G
Acta Physiol Acad Sci Hung; 1982; 60(4):213-8. PubMed ID: 6926659
[TBL] [Abstract][Full Text] [Related]
50. The kallikrein-kininogen-kinin system in patients with liver disease and ascites.
Solomon R; Azar P; Trebbin W; Weinberg MS
Nephron; 1988; 50(1):39-44. PubMed ID: 3173599
[TBL] [Abstract][Full Text] [Related]
51. [Kallikrein-kinin, prostaglandins and potassium metabolism].
Abe K; Haruyama T; Sato M
Nihon Rinsho; 1981 Feb; 39(2):285-91. PubMed ID: 7021904
[No Abstract] [Full Text] [Related]
52. Vasoactive factors in the mechanism of renal sodium handling in cirrhotics: the effect of acute plasma expansion.
Laffi G; La Villa G; Pinzani ; Mannelli M; Buzzelli G; Paladini S; Pampana A; Smorlesi C; Pedretti G; Gentilini P
Pharmacol Res Commun; 1984 Jun; 16(6):613-35. PubMed ID: 6431453
[TBL] [Abstract][Full Text] [Related]
53. Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism.
Lechi A; Covi G; Lechi C; Corgnati A; Arosio E; Zatti M; Scuro LA
Clin Sci Mol Med; 1978 Jul; 55(1):51-5. PubMed ID: 668267
[TBL] [Abstract][Full Text] [Related]
54. [Excretion of aldosterone in the urine, renin activity in the plasma and some indices of the metabolism of potassium and sodium in patients with the iodiopathic edema syndrome].
Egart FM; Atamanova TM; Egorova IA; Korotkova VD; Golokhvostova IF
Probl Endokrinol (Mosk); 1975; 21(3):45-9. PubMed ID: 1144321
[TBL] [Abstract][Full Text] [Related]
55. Urinary kallikrein activity is not altered in human essential hypertension.
Simonetti BM; Pierucci A; Taggi F; Morabito S; Vastano S; Marchetti S; Putini RL; Stirati G; Cinotti GA
Uremia Invest; 1985-1986; 9(2):189-93. PubMed ID: 3915922
[TBL] [Abstract][Full Text] [Related]
56. The kallikrein-kinin system and prostaglandins in the kidney: their relation to forosemide-induced diuresis and to the renin-angiotensin-aldosterone system in man.
Abe K; Irokawa N; Yasujima M; Seino M; Chiba S; Sakurai Y; Yoshinaga K; Saito T
Circ Res; 1978 Aug; 43(2):254-60. PubMed ID: 668057
[No Abstract] [Full Text] [Related]
57. Circulating kallikreins in normotensive and hypertensive humans: effects of mineralocorticoid administration.
Ohman KP
Blood Press; 1997 Jul; 6(4):214-22. PubMed ID: 9296308
[TBL] [Abstract][Full Text] [Related]
58. Altered urinary kallikrein excretion in human hypertension.
Margolis HS; Geller R; Pisano JJ; Sjoerdsma A
Lancet; 1971 Nov; 2(7733):1063-5. PubMed ID: 4106915
[No Abstract] [Full Text] [Related]
59. Urinary kallikrein and plasma renin during the reversal of renovascular hypertension in rats.
Gulati OP; Carretero OA; Morino T; Oza NB
Clin Sci Mol Med Suppl; 1976 Dec; 3():263s-266s. PubMed ID: 1071624
[TBL] [Abstract][Full Text] [Related]
60. Disorders of chloriuretic hormone secretion.
Grekin RJ; Nicholls MG; Padfield PL
Lancet; 1979 May; 1(8126):1116-8. PubMed ID: 86837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
